Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

5% minoxidil foam once daily works as well as 2% minoxidil solution twice daily for female hair growth and is more convenient.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

The most common skin problems in Indian children are infections and eczemas.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Mutations in the KRT85 gene cause hair and nail problems.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.